Certified in December 2017 by INCa (National Institute of Cancer), ILIAD is one of the eight SIRICs founded on the model of integration of Comprehensive Care Centre research.
ILIAD brings together medical, scientific and technological expertise while combining different disciplines (nuclear medicine, oncology, hematology, biological sciences, human and social sciences, epidemiology, chemistry, physics and mathematics) within a consortium of 9 research laboratories, 3 health establishments and 27 high level technological platforms.
ILIAD is underpinned by integrated research, which is innovative and multidisciplinary, structured around heterogeneity and tumour resistance. Articulated around the care pathway, the research carried out by the ILIAD teams also relates to the life of the patients by integrating the issues of social inequality and how to retain a job when faced with illness.
The research programmes are represented by two tumours which have been chosen as demonstrators: multiple myeloma and breast cancer.
A film on the Nantes nuclear medicine cluster is being shown throughout the SNMMI international congress being held in Vancouver from 11 to 14 June 2022. From bench to bedside: The uniqueness and [...]
The Montpellier Cancer SIRIC is co-organising with the 7 other French SIRICs a Workshop on the theme of Colorectal Cancer on 10 and 11 March 2022 at the IRCM. This event will be an opportunity to [...]